Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210030555 210010651 1.64 104.4 Palliative (P) null 2016-06-05 Temozolomide + RT 2 N 210025280 TEMOZOLOMIDE + RT
210030557 210010662 null 86.4 Adjuvant (A) null 2016-09-01 Trial Unspecified N null 210025401 TRIAL
210030558 210033363 null 91.2 Palliative (P) 2015-08-07 2015-08-13 Trial Unspecified 01 null 210025439 TRIAL
210030559 210010671 0 63.7 Disease modification (D) 2016-12-14 2017-02-10 Temozolomide + RT N null 210025489 TEMOZOLOMIDE + RT
210030560 210020934 1.6 118.4 Palliative (P) 2019-04-23 2019-04-23 CNS Medbl HR Cyclo+Vinc Y N 210025499 TRIAL
210030561 210010680 1.53 59.2 Palliative (P) 2013-06-28 2013-08-13 Temozolomide + RT 2 null 210025559 TEMOZOLOMIDE + RT
210030562 210010682 1.64 71.3 Palliative (P) 2014-10-04 2016-02-01 Trial Unspecified null Y 210025568 TRIAL
210030563 210010684 null 85 Palliative (P) 2016-12-14 2016-11-20 Temozolomide + RT 2 null 210025630 TEMOZOLOMIDE + RT
210030564 210010689 1.78 null Curative (C) 2017-05-17 2017-06-08 Temozolomide + RT N N 210025660 TEMOZOLOMIDE + RT
210030565 210010697 null 64.5 Curative (C) null 2016-02-19 Temozolomide + RT N 0 210025775 TEMOZOLOMIDE + RT
210030566 210033368 1.49 84.1 Curative (C) 2018-04-02 2018-04-09 ESPHALL TRIAL N N 210025796 TRIAL
210030567 210027247 1.79 66.5 Palliative (P) 2013-10-20 2013-11-04 Temozolomide + RT N N 210025802 TEMOZOLOMIDE + RT
210030568 210010707 1.63 75.7 Curative (C) 2014-09-11 2014-09-15 Trial Unspecified 01 N 210025884 TRIAL
210030569 210020979 1.8 38.3 Curative (C) 2017-02-12 2017-02-23 Trial Unspecified N N 210026347 TRIAL
210030570 210010736 1.63 47.4 Disease modification (D) 2019-03-07 2019-03-08 Trial Unspecified N N 210026367 TRIAL
210030571 210027256 null 59.2 Curative (C) null 2014-05-30 Temozolomide + RT N N 210026390 TEMOZOLOMIDE + RT
210030572 210010739 1.85 73.6 Palliative (P) 2019-09-05 2019-09-05 Trial Unspecified Y N 210026399 TRIAL
210030573 210010743 1.86 77.2 Disease modification (D) 2016-12-10 2017-01-20 Temozolomide + RT null N 210026489 TEMOZOLOMIDE + RT
210030574 210034970 1.19 null Not known (9) 2015-10-10 2015-11-04 Temozolomide + RT N Y 210026541 TEMOZOLOMIDE + RT
210030575 210010748 1.72 65.4 Curative (C) 2016-09-17 2016-09-17 Temozolomide + RT N N 210026580 TEMOZOLOMIDE + RT
210030576 210010750 1.8 74.4 Palliative (P) 2016-11-14 2016-11-14 Trial Unspecified 01 N 210026586 TRIAL
210030577 210010755 1.84 null Curative (C) 2014-10-28 2014-10-28 Trial Unspecified Y N 210026623 TRIAL
210030578 210034972 1.19 64 null 2017-07-09 2017-08-15 Temozolomide + RT 02 null 210026635 TEMOZOLOMIDE + RT
210030579 210020996 1.64 68.4 Disease modification (D) 2015-06-26 2015-06-27 Trial Unspecified null null 210026637 TRIAL
210030580 210010759 null null Adjuvant (A) 2017-08-16 2017-08-16 Temozolomide + RT 02 N 210026643 TEMOZOLOMIDE + RT
210030581 210027264 1.67 77.2 Disease modification (D) 2016-03-19 2016-03-19 Trial Unspecified N N 210026670 TRIAL
210030582 210010772 null 24.9 Adjuvant (A) 2017-03-16 2017-04-11 Temozolomide + RT N N 210026842 TEMOZOLOMIDE + RT
210030583 210010775 0 0 Palliative (P) 2017-11-06 2017-11-13 Trial Unspecified Y N 210026869 TRIAL
210030584 210010779 1.86 81.95 Disease modification (D) 2016-05-19 2016-07-03 Trial Unspecified Y N 210026889 TRIAL
210030585 210010782 1.16 null Unknown (U) 2019-01-14 2019-02-19 Trial Unspecified N N 210026910 TRIAL
210030586 210010784 1.76 47.4 Disease modification (D) 2018-01-29 2019-02-12 CNS HGG HERBY Bevacizumab 02 N 210026919 TRIAL
210030587 210010787 1.63 88.9 Palliative (P) 2015-05-21 2015-06-05 Temozolomide + RT N N 210026938 TEMOZOLOMIDE + RT
210030588 210010790 1.64 null Palliative (P) 2014-04-08 2014-04-14 Trial Unspecified Y N 210026957 TRIAL
210030589 210010793 1.65 77.6 Palliative (P) 2014-01-18 2014-02-22 Trial Unspecified Y Y 210026998 TRIAL
210030590 210010796 null 80.8 Curative (C) 2014-06-09 2014-08-24 Temozolomide + RT 2 N 210027027 TEMOZOLOMIDE + RT
210030591 210010800 null 52.7 Adjuvant (A) 2016-08-17 2016-08-26 Trial Unspecified N N 210027028 TRIAL
210030592 210010803 null 85.2 Disease modification (D) 2015-11-29 2015-12-02 ESPHALL TRIAL Y null 210027036 TRIAL
210030593 210010809 1.76 49.5 Disease modification (D) 2014-06-13 2014-07-24 Temozolomide + RT N N 210027055 TEMOZOLOMIDE + RT
210030594 210010810 1.8 null Curative (C) 2017-09-17 2017-09-17 Trial Unspecified N N 210027080 TRIAL
210030595 210010811 1.72 72 Curative (C) 2015-01-01 2015-05-20 Trial Unspecified N null 210027083 TRIAL
210030596 210010812 null 65.4 Palliative (P) 2017-09-03 2017-09-14 Temozolomide + RT 02 null 210027099 TEMOZOLOMIDE + RT
210030597 210027288 null 63 Curative (C) 2015-05-21 2015-06-24 Temozolomide + RT N null 210027114 TEMOZOLOMIDE + RT
210030598 210010816 1.6 79 null 2014-04-17 2014-05-07 Temozolomide + RT N null 210027124 TEMOZOLOMIDE + RT
210030599 210010822 1.78 82.4 Curative (C) 2017-03-12 2017-03-17 Trial Unspecified 1 Y 210027159 TRIAL
210030600 210010823 1.75 109.6 Palliative (P) 2016-06-07 2016-06-24 Temozolomide + RT N N 210027183 TEMOZOLOMIDE + RT
210030601 210010825 1.8 65.4 Adjuvant (A) 2014-05-10 2014-06-07 Temozolomide + RT 02 N 210027184 TEMOZOLOMIDE + RT
210030602 210010829 1.81 null Curative (C) 2018-02-15 2018-03-26 Trial Unspecified Y Y 210027205 TRIAL
210030603 210010846 null 111 Disease modification (D) 2017-12-18 2018-02-26 Temozolomide + RT 02 N 210027322 TEMOZOLOMIDE + RT
210030604 210010850 1.7 null Neo-adjuvant (N) 2013-12-18 2014-01-09 ESPHALL TRIAL Y N 210027335 TRIAL
210030605 210010857 null 55.8 Palliative (P) 2017-10-27 2017-11-24 Temozolomide + RT 02 N 210027382 TEMOZOLOMIDE + RT